Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis

Isabelle Marc,Pascal M Lavoie,Andrew J Mcphee,Carmel T Collins,David Simonyan,Etienne Pronovost,Mireille Guillot,Jacqueline F Gould,Ibrahim Mohamed,Marc Beltempo,Amélie Boutin,Isabel Fortier,Thomas R Sullivan,Lynne Moore,Maria Makrides

doi:10.1136/bmjopen-2023-076223

Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis

Isabelle Marc, Pascal M Lavoie + Show 13 more

Open Access

https://doi.org/10.1136/bmjopen-2023-076223

Copy DOI

Journal: BMJ open	Publication Date: Jul 1, 2023
License type: CC BY-NC 4.0

Affiliation: Université Laval, University of British Columbia, University of Adelaide, Université de Montréal, McGill University Health Centre, McGill University

#Individual Participant Data Meta-analysis #Risk Of Bronchopulmonary Dysplasia + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionSevere bronchopulmonary dysplasia (BPD) is a well-known factor consistently associated with impaired cognitive outcomes. Regarding reported benefits on long-term neurodevelopmental outcomes, the potential adverse effects of high-dose docosahexaenoic acid (DHA)...

Full Text